A Post Market Device Study for the Treatment of Acne

NCT06469398 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-03-17

No results posted yet for this study

Summary

To evaluate the safety and efficacy of the Cutera laser system for the treatment of acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

DEVICE

Cutera Laser System

Subjects will receive up to 6 laser treatments

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-21
Primary Completion
2025-03-31
Completion
2025-08-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06469398 on ClinicalTrials.gov